%0 Journal Article
%T The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance
%A Bryson W. Katona
%A David C. Metz
%A Emma E. Furth
%A Kristen Stashek
%A Nadim Mahmud
%A Rashmi Tondon
%A Robert Roses
%A Stuti G. Shroff
%J Archive of "Annals of Gastroenterology".
%D 2019
%R 10.20524/aog.2018.0325
%X Autoimmune metaplastic atrophic gastritis (AMAG) is an immune-mediated process that may lead to pernicious anemia (PA) and an increased risk of gastric cancer. Although some literature supports 3- or 5-year endoscopic surveillance for gastric cancer in patients with PA, no formal guidance exists for the general AMAG population. We sought to identify the prevalence and incidence rates of dysplasia or adenocarcinoma in patients with AMAG in order to clarify endoscopic best practices
%K Autoimmune metaplastic atrophic gastritis
%K incidence
%K gastric adenocarcinoma
%K surveillance
%K upper endoscopy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302190/